provide business development efforts for building portfolio of PPEs, hand sanitizers, disinfectants and related products related to hygiene and prevent microbial spreading, identify and analyze novel products under development or on market that would fit into portfolio, provide medical, regulatory scientific support for company

Provide services relating to:

1. drug development strategy, preclinical and clinical plan development, regulatory and re-imbursement strategy.
•
2. commercial strategy, forecasting, technology assessment, valuation, licensing, due diligence

3. business plan development, pitch deck preparation, IP strategy, presenting to investor and companies

represent company at partnering and investor meetings as part of raising capital, develop commercial strategy and efforts necessary to move programs forwards including preclinical, clinical and regulatory activities, work with knowledge leaders to shape and determine value proposition of programs underway and identify differentiating factors that could be incorporated in clinical trials, marketing and regulatory activities

Conceptualized and incorporated strategies to demonstrate unique compound features to address unmet clinical needs, product differentiation, PK, safety or patentability for preclinical and clinical studies; led IP portfolio and business development efforts, including licensing and identification of potential oportunities.

Led commercial strategy efforts for early stage development programs and business development opportunities within CVM Therapy Unit. Represented Therapy Unit as Commercial Lead for Clinical Development teams, US, EU, Japan and Emerging Market business units, Worldwide Business Development group, Regulatory Affairs, Portfolio Management group, Manufacturing, and Market Access groups. Managed internal and external personnel in primary/secondary market research and competitive intelligence effor

Identified additional indications as part of life cycle strategies for new products. Responsible for protecting value of company’s products and inventions by managing intellectual property (IP) strategy. Member of due diligence team for assessing in-licensing/acquisition opportunities. Directed qualitative/quantitative market research projects with external vendors to develop forecasts Organized and chaired portfolio management group which enhanced executive decision making capabilities

Formulated strategies and identified issues for lead attorneys and partners regarding freedom to operate, patent infringement and competitive barriers for clients’ IP portfolios in litigation, prosecution or under licensing consideration. Performed due diligence analysis on novel technologies. Advised attorneys during deposition process.

Led consulting teams on major assignments for top multinational pharmaceutical, biotech, diagnostic and medical device companies, start-ups and individual inventors to resolve issues concerning unmet need gaps, technology assessment, clinical impact and real market potential for emerging therapeutics. Provided assessments of business threats, licensing opportunities, enhancement of product portfolios, and competitive environment analysis.

Company pharmacologist for start-up venture. Managed scientists and research associates in evaluating proof of concept, pharmacology, pharmacokinetics, safety and toxicology of potential therapeutic agents, with annual budget of $2 million. Reported project updates to Board of Directors. As part of business development team, presented therapeutic potentials of R & D programs to potential partners. Designed aspects of Phase I, II and III clinical trials.